Phase 1 significant effects. by Wendy C. Crone (2262169)

Nasal microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Gut microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

Comparison of the study groups in terms of the mean score of VAS scale, on days 1,7,10, and 14 post-intervention. by Masoumeh Sayahi (17468290)

Subjects:

Flowchart of study participants. by Masoumeh Sayahi (17468290)

Subjects:

Examination of the effect of treatment groups, different times and the effect of group* time, for VAS and REEDA indicators. by Masoumeh Sayahi (17468290)

Subjects:

Comparison of sociodemographic characteristics of participants in two groups of intervention and control. by Masoumeh Sayahi (17468290)

Subjects:

Comparison of the study groups in terms of the mean score of REEDA scale, on days 1,7,10 and 14 post-intervention. by Masoumeh Sayahi (17468290)

Subjects:

Highest Eulerian distance. by Søren O’Neill (8638140)

Median Eulerian distance. by Søren O’Neill (8638140)

Lowest Eulerian distance. by Søren O’Neill (8638140)

Clinical significance of <i>STM</i>_<i>FCS</i>. by Peter A. Pahapill (8468607)

Outcome variable descriptive statistics. by Kristen S. Regenauer (13842386)

Subjects:

Demographic & job characteristics. by Kristen S. Regenauer (13842386)

Subjects:

Training feedback. by Kristen S. Regenauer (13842386)

Subjects:

Study flow. by Kristen S. Regenauer (13842386)

Subjects:

Consort 2010 flow diagram. by Amit Singla (739378)

Subjects:

Overall K-M Mortality (a), day 14 (b) and day 28 (c). by Amit Singla (739378)

Subjects:

The dependency of thrombolysis on rt-PA concentration. by Jan Víteček (11434774)